CPR Pharma Services Pty Ltd finalised a total 2.52 million dollar investment in April to expand bioanalytical capabilities at its Thebarton laboratory.

The combined investment from Adelaide based life science fund Terra Rossa Capital and Itek Pty Ltd, the commercialisation arm of the University of South australia leveraged up the recent Innovation and Investment Fund for South Australia (IIFSA) funding won by CPR and provided additional working capital for business expansion. 

CPR now has the capital required to develop the capabilities of its Thebarton laboratory and  promote its services globally.